+ All Categories
Home > Documents > Abbot Drugs

Abbot Drugs

Date post: 05-Apr-2018
Category:
Upload: joch6403
View: 231 times
Download: 0 times
Share this document with a friend
32
Atracurium Class: Nondepolarizing neuromuscular blocking agent Uses: Skeletal muscle relaxation Action: Competes with ACH at nicotinic receptor site (blocks Na, interfering with ACH at nerve ending) Onset: 1-5 minutes Duration: 20-60 minutes Half life: 22 minutes Dose Intubation 0.5 mg/kg ED 95 0.2 mg/kg 30% in volatile agents Maintenance N/A Infusion N/A Pediatric reduce dose 25% in neonates Metabolism: Laudanosine; Hoffman elimination and ester hydrolysis, slowed by acidosis pH<7.4 and body temp. <37 degrees Celsius. Laudanosine is eliminated by bile and renal elimi nation. Laudanos ine crosses the BBB and can cause seizures with high doses. T 1/2 150 minutes. Pregnancy class Short acting; 5-20% transferred to baby Contraindications NA Adverse reactions: Seizures with high doses. Good for patients with renal or hepatic disease. Pediatric use: 5% dose reduction in neonates, otherwise no change in dose per weight. Antidote: Reversed by neostigmine, edrophonium, pyridostigmine ; acts as antagonist.
Transcript

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 1/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 2/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 3/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 4/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 5/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 6/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 7/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 8/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 9/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 10/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 11/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 12/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 13/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 14/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 15/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 16/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 17/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 18/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 19/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 20/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 21/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 22/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 23/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 24/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 25/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 26/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 27/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 28/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 29/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 30/31

7/31/2019 Abbot Drugs

http://slidepdf.com/reader/full/abbot-drugs 31/31


Recommended